Related Experiment Videos
MAO inhibitors: pharmacodynamic aspects and clinical implications
1Frederiksberg Hospital, Department of Psychiatry, Copenhagen, Denmark.
Acta Psychiatrica Scandinavica. Supplementum
|January 1, 1988
Summary
Monoamine oxidase inhibitors (MAOIs) are safe and effective antidepressants, particularly for atypical symptoms. Careful patient compliance is crucial due to potential interactions.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Monoamine oxidase inhibitors (MAOIs) remain vital in treating depression.
- MAOIs are generally safe and well-tolerated, comparable to cyclic antidepressants.
Purpose of the Study:
- To review the therapeutic role and safety of MAO inhibitors in psychiatric disorders.
- To highlight patient selection criteria and necessary precautions for MAOI use.
Main Methods:
- Literature review of recent studies on MAO inhibitors.
- Analysis of MAOI efficacy in various depressive subtypes and psychiatric conditions.
Main Results:
- MAOIs show efficacy in atypical depressive symptoms (weight gain, sleep, libido changes).
- They are also effective for anxiety, phobias, hysteroid dysphoria, and treatment-refractory depression.
- MAOIs are as safe and tolerated as cyclic antidepressants in most cases.
Conclusions:
- MAO inhibitors are valuable therapeutic options for a broad range of psychiatric disorders.
- Their use requires careful patient selection and strict adherence to dietary and drug interaction guidelines due to potential hazards.